| Dr Charles L Hobbs, MD | |
|
1941 Limestone Rd Ste 213, Wilmington, DE 19808-5400 | |
| (302) 892-2100 | |
| (302) 992-9017 |
| Full Name | Dr Charles L Hobbs |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 1941 Limestone Rd Ste 213, Wilmington, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366553851 | NPI | - | NPPES |
| 1366553851 | Medicaid | DE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | C10001979 (Delaware) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles L Hobbs, MD 1941 Limestone Rd Ste 213, Wilmington, DE 19808-5400 Ph: (302) 892-2100 | Dr Charles L Hobbs, MD 1941 Limestone Rd Ste 213, Wilmington, DE 19808-5400 Ph: (302) 892-2100 |
News Archive
New research from UC Davis published in the Proceedings of the National Academy of Sciences shows that blocking an enzyme that promotes inflammation can prevent the tissue damage following a heart attack that often leads to heart failure.
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced that during a special meeting of stockholders held today, its stockholders approved the proposal to issue shares of the Company's common stock and warrants to purchase shares of the Company's common stock to Symphony Capital Partners, LP and their co-investors. Subsequent to this vote, Alexza completed its acquisition of Symphony Allegro, and as a result, Alexza reacquired all rights to AZ-004, AZ-104 and AZ-002.
In an advance toward development of a nasal spray that protects against infection with influenza and spread of the disease, scientists are reporting identification of a substance that activates the first-line defense system against infection inside the nose. They describe effects of a synthetic form of a natural substance found in bacterial cell walls in ACS' journal Molecular Pharmaceutics.
Benitec Biopharma Limited, a clinical-stage biotechnology company developing innovative therapeutics based on its gene-silencing technology, DNA-directed RNA interference (ddRNAi), is pleased to announce it has initiated a new site for its ongoing Phase 1/2a TT-034 trial at the Methodist Health System Clinical Research Institute in Dallas, Texas.
Neurological diseases like Alzheimer's disease, Parkinson's disease, depression, pain disorders and addictions could now be treated from within the brain itself using an intriguing new soft implant in the brain itself.
› Verified 7 days ago
Dr. Chukwuemeka Felix Mbadiwe, Surgery Medicare: Not Enrolled in Medicare Practice Location: 1405 Fresno Rd, Wilmington, DE 19803 Phone: 302-477-0752 Fax: 302-477-0752 | |
Dr. Kirk W. Reichard, MD Surgery Medicare: Medicare Enrolled Practice Location: A.i. Dupont Hospital For Children, 1600 Rockland Road, Wilmington, DE 19803 Phone: 302-651-4000 Fax: 302-651-4945 | |
Dr. Danielle Press, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1401 Foulk Rd Ste 207, Wilmington, DE 19803 Phone: 302-475-4900 Fax: 302-475-4907 | |
Dr. Matthew Mikhail Boelig, MD Surgery Medicare: Medicare Enrolled Practice Location: 1600 Rockland Rd, Wilmington, DE 19803 Phone: 302-651-4200 | |
Dr. Michael B Goldberg, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 501 W 14th St, Wilmington, DE 19801 Phone: 302-320-4175 | |
Ms. Analene Tunacao, CRNP Surgery Medicare: Not Enrolled in Medicare Practice Location: 1601 Kirkwood Hwy, Wilmington, DE 19805 Phone: 302-994-2511 | |
Dr. Charles D. Vinocur, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: A.i. Dupont Hospital For Children, 1600 Rockland Road, Wilmington, DE 19803 Phone: 302-651-4000 Fax: 302-651-4945 |